Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490815 · ClinicalTrials.gov registry record · Phase 3
Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema
A Phase 3 study, sponsored by Alimera Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 37
- Enrollment target
NCT00490815 is a Phase 3 study that has completed, run by Alimera Sciences. The registered enrollment target is 37 participants.
The verdict
NCT00490815, a Phase 3 study, has completed, sponsored by Alimera Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 37 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetics, safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema
Interventions
- DRUG Fluocinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00490815
The ClinicalTrials.gov registry entry for NCT00490815 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alimera Sciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone Acetonide is the first listed.
NCT00490815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00490815 about?
NCT00490815 is a clinical study titled "Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema". This study will evaluate the pharmacokinetics, safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema
What is the current status of trial NCT00490815?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 37 participants. The study started on 2007-08. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00490815?
The interventions under investigation include: Fluocinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT00490815?
This trial is sponsored by Alimera Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.